Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent
To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent...
Brief Summary
To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Intervention(s) in this Clinical Trial
- Drug: Crinone Gel 8%
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies -
- No medications for PTL or any kind of progesterone.
- Cervical suture
- Multiple pregnancy
Exclusion Criteria:
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: The Baruch Padeh Medical Center, Poriya Other
Overall Clinical Trial Officials and Contacts
Yuri Perlitz, MD Study Chair The Baruch Padeh Medical Center, Poriya
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00329316
Study ID Number: PTL Progesterone Perlitz.CTIL
ClinicalTrials.gov Identifier: NCT00329316
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00329316
